Murad Gezer
Murad Gezer has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Oya Demirci
Department of Obstetrics, Division of Perinatology, Zeynep Kamil Women and Children's Diseases Training and Research Hospital, Istanbul, Turkey
6 shared publications- Ümit Taşdemir
Division of Perinatology, Department of Obstetrics, Konya City Hospital, Konya, Turkey
6 shared publications - Mucize Eriç Özdemir
Department of Obstetrics, Division of Perinatology Zeynep Kamil Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi Istanbul Turkey
5 shared publications - Oya Demirci
Department of Obstetrics, Division of Perinatology Zeynep Kamil Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi Istanbul Turkey
4 shared publications - Ömer Gökhan Eyisoy
Department of Perinatology, Clinic of Obstetrics and Gynecology Yozgat City Hospital Yozgat Turkey
4 shared publications - Halise Hande Gezer
Rheumatology Division, Physical Medicine and Rehabilitation Department, Marmara University School of Medicine, Istanbul, Türkiye
3 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (1) , 146-152
Psoriatic arthritis and pregnancy: maternal and neonatal outcomes in a clinical cohort
Aims: To evaluate obstetric and neonatal outcomes in women with psoriatic arthritis (PsA) by comparing pregnancies before and after diagnosis, as well as with healthy controls, with a focus on disease activity, treatment exposure, and flares Methods: This retrospective cross-sectional study included 227 pregnancies from 85 women with PsA and 100 pregnancies from 46 healthy controls. Maternal and neonatal outcomes were assessed, including preeclampsia, gestational hypertension, gestational diabetes, cesarean delivery, preterm birth, small for gestational age (SGA), congenital anomalies, and neonatal intensive care unit (NICU) admissions. Disease activity and flares during pregnancy were recorded. Logistic regression analyses were performed to identify predictors of composite adverse maternal and neonatal outcomes. Results: Among PsA pregnancies, 161 (71%) occurred before and 66 (29%) after diagnosis. Maternal age at conception was higher post-diagnosis, and these pregnancies showed increased rates of cesarean delivery (60.4% vs. 16.9% and 14.5%, p
- 6 January 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (1) , 146-152
Open AccessPsoriatic arthritis and pregnancy: maternal and neonatal outcomes in a clinical cohort
Aims: To evaluate obstetric and neonatal outcomes in women with psoriatic arthritis (PsA) by comparing pregnancies before and after diagnosis, as well as with healthy controls, with a focus on disease activity, treatment exposure, and flares Methods: This retrospective cross-sectional study included 227 pregnancies from 85 women with PsA and 100 pregnancies from 46 healthy controls. Maternal and neonatal outcomes were assessed, including preeclampsia, gestational hypertension, gestational diabetes, cesarean delivery, preterm birth, small for gestational age (SGA), congenital anomalies, and neonatal intensive care unit (NICU) admissions. Disease activity and flares during pregnancy were recorded. Logistic regression analyses were performed to identify predictors of composite adverse maternal and neonatal outcomes. Results: Among PsA pregnancies, 161 (71%) occurred before and 66 (29%) after diagnosis. Maternal age at conception was higher post-diagnosis, and these pregnancies showed increased rates of cesarean delivery (60.4% vs. 16.9% and 14.5%, p
- 3 January 2026
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (4) , 420-426
Behçet’s Disease and Pregnancy: Increased Risk of Preterm Birth and the Role of Mucocutaneous Activity
Objective: This study aimed to evaluate and compare the pregnancy outcomes of women with Behçet’s disease (BD) before and after the diagnosis. Methods: This retrospective cross-sectional study included 100 pregnancies from 30 women diagnosed with BD. Clinical characteristics, treatments, and obstetric outcomes were assessed. Pregnancy outcomes were compared between those occurring before and after BD diagnosis. Additionally, factors associated with live birth without adverse outcomes were analyzed. Results: Of the 100 pregnancies, 52 occurred before and 48 after the diagnosis of BD. The post-diagnosis group had significantly lower gestational age at delivery (p < 0.001), a higher rate of preterm birth (25.7% vs. 7.3%, p = 0.03), and increased cesarean delivery rates (54.3% vs. 19.5%, p = 0.002). No significant differences were observed in miscarriage, NICU admission, neonatal jaundice, anomaly, or perinatal mortality. In multivariate analysis, erythema nodosum was the only independent predictor of adverse pregnancy outcomes (OR 5.66, 95% CI: 1.07–29.92, p = 0.041). Conclusion: Pregnancies following the diagnosis of BD are associated with increased risks of preterm birth and cesarean delivery. Patients with erythema nodosum was independently associated with adverse obstetric outcomes. Close monitoring remains essential to optimize maternal and fetal health in patients with BD.
- 3 January 2026
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (4) , 420-426
Behçet’s Disease and Pregnancy: Increased Risk of Preterm Birth and the Role of Mucocutaneous Activity
Objective: This study aimed to evaluate and compare the pregnancy outcomes of women with Behçet’s disease (BD) before and after the diagnosis. Methods: This retrospective cross-sectional study included 100 pregnancies from 30 women diagnosed with BD. Clinical characteristics, treatments, and obstetric outcomes were assessed. Pregnancy outcomes were compared between those occurring before and after BD diagnosis. Additionally, factors associated with live birth without adverse outcomes were analyzed. Results: Of the 100 pregnancies, 52 occurred before and 48 after the diagnosis of BD. The post-diagnosis group had significantly lower gestational age at delivery (p < 0.001), a higher rate of preterm birth (25.7% vs. 7.3%, p = 0.03), and increased cesarean delivery rates (54.3% vs. 19.5%, p = 0.002). No significant differences were observed in miscarriage, NICU admission, neonatal jaundice, anomaly, or perinatal mortality. In multivariate analysis, erythema nodosum was the only independent predictor of adverse pregnancy outcomes (OR 5.66, 95% CI: 1.07–29.92, p = 0.041). Conclusion: Pregnancies following the diagnosis of BD are associated with increased risks of preterm birth and cesarean delivery. Patients with erythema nodosum was independently associated with adverse obstetric outcomes. Close monitoring remains essential to optimize maternal and fetal health in patients with BD.
- 11 November 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (11) , e70136
Vasomotor Symptoms Are Linked to Vascular and Cartilage Structural Changes in Postmenopausal Women
Objectives: Vasomotor symptoms (VMS), including hot flashes and night sweats, are among the most common and distressing symptoms during the menopausal period. This study aimed to evaluate the relationship between VMS and carotid intima‐media thickness (CIMT) and femoral cartilage thickness (FCT) in postmenopausal women. Materials and Methods: This cross‐sectional study included 50 postmenopausal women. Demographic data, body mass index, lipid profile, and menopausal characteristics were collected. CIMT was measured using high‐resolution B‐mode ultrasound, while femoral cartilage thickness was evaluated through knee ultrasound. Multivariate logistic regression analysis was performed to identify independent predictors of VMS. Results: The mean age of the patients was 54.3 (SD: 4.4), and 70% of them had VMS. CIMT was significantly higher and FCT significantly lower in women with VMS ( p < 0.05). Logistic regression revealed that increased CIMT (OR = 27.97, 95% CI: 1.008–776.4, p = 0.049) and decreased medial FCT (OR = 0.008, 95% CI: 0.000–0.574, p = 0.027) were independently associated with the presence of VMS, regardless of age, BMI, and menopause duration. Conclusion: Vasomotor symptoms are associated with increased carotid intima‐media thickness and reduced femoral cartilage thickness in postmenopausal women.
- 11 November 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (11) , e70136
Vasomotor Symptoms Are Linked to Vascular and Cartilage Structural Changes in Postmenopausal Women
Objectives: Vasomotor symptoms (VMS), including hot flashes and night sweats, are among the most common and distressing symptoms during the menopausal period. This study aimed to evaluate the relationship between VMS and carotid intima‐media thickness (CIMT) and femoral cartilage thickness (FCT) in postmenopausal women. Materials and Methods: This cross‐sectional study included 50 postmenopausal women. Demographic data, body mass index, lipid profile, and menopausal characteristics were collected. CIMT was measured using high‐resolution B‐mode ultrasound, while femoral cartilage thickness was evaluated through knee ultrasound. Multivariate logistic regression analysis was performed to identify independent predictors of VMS. Results: The mean age of the patients was 54.3 (SD: 4.4), and 70% of them had VMS. CIMT was significantly higher and FCT significantly lower in women with VMS ( p < 0.05). Logistic regression revealed that increased CIMT (OR = 27.97, 95% CI: 1.008–776.4, p = 0.049) and decreased medial FCT (OR = 0.008, 95% CI: 0.000–0.574, p = 0.027) were independently associated with the presence of VMS, regardless of age, BMI, and menopause duration. Conclusion: Vasomotor symptoms are associated with increased carotid intima‐media thickness and reduced femoral cartilage thickness in postmenopausal women.
- Open Access
- 3 October 2025
- Published by Academician Publishing
Güncel Kadın Hastalıkları ve Doğum Çalışmaları X (AYBAK 2025 Güz)
- 3 October 2025
- Published by Academician Publishing
Open AccessGüncel Kadın Hastalıkları ve Doğum Çalışmaları X (AYBAK 2025 Güz)
- Open Access
- 3 October 2025
- Published by Academician Publishing
- p. 63-70
Preterm Doğumda Nöroprotektif Magnezyum Kullanımı
Preterm doğum, neonatal mortalite ve morbiditenin başlıca nedenlerinden biridir ve hayatta kalan bebeklerde serebral palsi (SP) riski belirgin şekilde artmaktadır. SP için kesin tedavi bulunmadığından, antenatal dönemde uygulanabilecek koruyucu yaklaşımlar kritik önemdedir. Bu kapsamda magnezyum sülfatın preterm doğum riski taşıyan gebelerde fetal nöroprotektif potansiyeli çok sayıda randomize kontrollü çalışma ve meta-analiz ile araştırılmıştır. ACTOMgSO₄, BEAM, PREMAG ve MAGENTA çalışmaları, farklı doz ve protokollerle uygulanmış olup özellikle BEAM çalışmasında orta-şiddetli SP insidansında anlamlı azalma gösterilmiştir. 2024 Cochrane meta-analizi, magnezyum sülfatın ölüm veya SP riskini iki yaşına kadar azalttığını, ancak uzun dönem takiplerde etkinin istatistiksel olarak anlamlı olmadığını bildirmiştir. Klinik uygulamada, 24–32. gebelik haftaları arasında, doğumun 24 saat içinde gerçekleşme olasılığı yüksek gebelikler tedavi için uygun adaylardır. Uygulama genellikle 6 g yükleme ve 2 g/saat idame şeklinde yapılmakta, maksimum 24 saat ile sınırlandırılmaktadır. Kontrendikasyonlar arasında myastenia gravis öne çıkarken, böbrek fonksiyon bozukluğunda doz ayarlaması gerekmektedir. Antenatal kortikosteroidlerle kombine kullanım, özellikle aşırı preterm olgularda mortalite ve majör nörogelişimsel bozukluk riskini azaltıcı sinerjik etki sunmaktadır.
- 3 October 2025
- Published by Academician Publishing
- p. 63-70
Open AccessPreterm Doğumda Nöroprotektif Magnezyum Kullanımı
Preterm doğum, neonatal mortalite ve morbiditenin başlıca nedenlerinden biridir ve hayatta kalan bebeklerde serebral palsi (SP) riski belirgin şekilde artmaktadır. SP için kesin tedavi bulunmadığından, antenatal dönemde uygulanabilecek koruyucu yaklaşımlar kritik önemdedir. Bu kapsamda magnezyum sülfatın preterm doğum riski taşıyan gebelerde fetal nöroprotektif potansiyeli çok sayıda randomize kontrollü çalışma ve meta-analiz ile araştırılmıştır. ACTOMgSO₄, BEAM, PREMAG ve MAGENTA çalışmaları, farklı doz ve protokollerle uygulanmış olup özellikle BEAM çalışmasında orta-şiddetli SP insidansında anlamlı azalma gösterilmiştir. 2024 Cochrane meta-analizi, magnezyum sülfatın ölüm veya SP riskini iki yaşına kadar azalttığını, ancak uzun dönem takiplerde etkinin istatistiksel olarak anlamlı olmadığını bildirmiştir. Klinik uygulamada, 24–32. gebelik haftaları arasında, doğumun 24 saat içinde gerçekleşme olasılığı yüksek gebelikler tedavi için uygun adaylardır. Uygulama genellikle 6 g yükleme ve 2 g/saat idame şeklinde yapılmakta, maksimum 24 saat ile sınırlandırılmaktadır. Kontrendikasyonlar arasında myastenia gravis öne çıkarken, böbrek fonksiyon bozukluğunda doz ayarlaması gerekmektedir. Antenatal kortikosteroidlerle kombine kullanım, özellikle aşırı preterm olgularda mortalite ve majör nörogelişimsel bozukluk riskini azaltıcı sinerjik etki sunmaktadır.
- 6 September 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (9) , 1-9
Obstetric and neonatal outcomes in pregnancies with familial mediterranean fever: a comparative study
Familial Mediterranean Fever (FMF) is frequently diagnosed during reproductive ages, but its impact on pregnancy remains unclear. We aimed to evaluate maternal and neonatal outcomes in FMF pregnancies by comparing before and after diagnosis periods as well as with healthy controls, and to identify predictors of adverse outcomes. This retrospective, cross-sectional study included 215 pregnancies (129 before and 86 after FMF diagnosis) from 81 women with FMF and 94 pregnancies from 42 healthy controls. Demographic data, disease characteristics, medications, and genetic mutations were recorded. Maternal and neonatal outcomes were compared, and multivariate logistic regression was used to identify predictors of adverse maternal outcomes. After FMF diagnosis, live birth occurred in 69 cases (80.2%), miscarriage in 15 (17.4%), and stillbirth in 2 (2.3%). In contrast, before diagnosis, live birth occurred in 104 cases (80.6%), miscarriage in 17 (13.4%), and stillbirth in 7 (5.4%). Among pregnancies after diagnosis, cesarean section was more frequent (38 cases, 53.5% vs. 29 cases, 25.9%, p < 0.001), as well as adverse maternal outcomes (58 cases, 67.4% vs. 63 cases, 48.8%, p = 0.007), compared to before diagnosis. Compared with controls, FMF patients showed no significant differences in maternal or neonatal outcomes. Among 86 pregnancies after diagnosis, colchicine was used in 66 (76.7%), and FMF flares were reported in 22 cases (31.9%) among pregnancies resulting in live birth, most commonly during the second trimester. Logistic regression identified older maternal age (OR 1.12, 95% CI: 1.02–1.25, p = 0.02) and disease flares before pregnancy (OR 6.96, 95% CI: 1.40–34.58, p = 0.02) as independent predictors of adverse maternal outcomes. Maternal and neonatal outcomes in FMF pregnancies were comparable to those in controls. Advanced maternal age and disease activity before conception were identified as independent predictors of adverse maternal outcomes.
- 6 September 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (9) , 1-9
Obstetric and neonatal outcomes in pregnancies with familial mediterranean fever: a comparative study
Familial Mediterranean Fever (FMF) is frequently diagnosed during reproductive ages, but its impact on pregnancy remains unclear. We aimed to evaluate maternal and neonatal outcomes in FMF pregnancies by comparing before and after diagnosis periods as well as with healthy controls, and to identify predictors of adverse outcomes. This retrospective, cross-sectional study included 215 pregnancies (129 before and 86 after FMF diagnosis) from 81 women with FMF and 94 pregnancies from 42 healthy controls. Demographic data, disease characteristics, medications, and genetic mutations were recorded. Maternal and neonatal outcomes were compared, and multivariate logistic regression was used to identify predictors of adverse maternal outcomes. After FMF diagnosis, live birth occurred in 69 cases (80.2%), miscarriage in 15 (17.4%), and stillbirth in 2 (2.3%). In contrast, before diagnosis, live birth occurred in 104 cases (80.6%), miscarriage in 17 (13.4%), and stillbirth in 7 (5.4%). Among pregnancies after diagnosis, cesarean section was more frequent (38 cases, 53.5% vs. 29 cases, 25.9%, p < 0.001), as well as adverse maternal outcomes (58 cases, 67.4% vs. 63 cases, 48.8%, p = 0.007), compared to before diagnosis. Compared with controls, FMF patients showed no significant differences in maternal or neonatal outcomes. Among 86 pregnancies after diagnosis, colchicine was used in 66 (76.7%), and FMF flares were reported in 22 cases (31.9%) among pregnancies resulting in live birth, most commonly during the second trimester. Logistic regression identified older maternal age (OR 1.12, 95% CI: 1.02–1.25, p = 0.02) and disease flares before pregnancy (OR 6.96, 95% CI: 1.40–34.58, p = 0.02) as independent predictors of adverse maternal outcomes. Maternal and neonatal outcomes in FMF pregnancies were comparable to those in controls. Advanced maternal age and disease activity before conception were identified as independent predictors of adverse maternal outcomes.
- 1 August 2025
- Published by Elsevier in Early Human Development
- Vol. 209, 106355
Prenatal and postnatal outcomes in fetuses with ventriculomegaly: Prognostic factors insights from a single-center study
- 1 August 2025
- Published by Elsevier in Early Human Development
- Vol. 209, 106355
Prenatal and postnatal outcomes in fetuses with ventriculomegaly: Prognostic factors insights from a single-center study
- Open Access
- 28 July 2025
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 53 (9) , 1230-1237
Liver fibrosis markers as predictors of adverse outcomes in pregnancy-related hypertensive disorders
Objectives: This study aimed to compare noninvasive liver fibrosis markers, including the Aspartate Aminotransferase Platelet Ratio Index (APRI) and FIB-4, between patients with hypertensive disorders of pregnancy (HDP) and healthy controls and to investigate the association between these markers and adverse maternal and perinatal outcomes. Methods: In this retrospective case-control study, 205 patients with HDP and 192 normotensive controls were included for evaluation. Demographic data, laboratory findings, and maternal and perinatal outcomes were compared. FIB-4 and APRI scores were calculated using second-trimester AST, ALT, and platelet levels. ROC curve analysis was used to assess the predictive accuracy of these indices for HELLP syndrome and other complications. Linear regression analysis was applied to evaluate the parameters associated with the FIB-4 score. Results: FIB-4 and APRI scores were significantly higher in patients with HDP compared to controls (p<0.05). Among patients with severe preeclampsia and HELLP syndrome, fibrosis scores were markedly elevated. FIB-4 and APRI showed excellent diagnostic performance for HELLP syndrome (AUC: 0.976 and 0.992, respectively), with optimal cutoffs of 1.52 and 0.7. However, their predictive role for general adverse maternal and perinatal outcomes was limited. In multivariate regression, systolic blood pressure, maternal age, and adverse maternal outcomes were independent predictors of increased FIB-4 scores (p<0.05). Conclusions: FIB-4 and APRI may be considered simple, noninvasive indices that could contribute to early risk stratification for HELLP syndrome among patients with HDP. Although their predictive capacity remains to be validated in larger prospective studies, they may offer preliminary insights into hepatic dysfunction during pregnancy.
- 28 July 2025
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 53 (9) , 1230-1237
Open AccessLiver fibrosis markers as predictors of adverse outcomes in pregnancy-related hypertensive disorders
Objectives: This study aimed to compare noninvasive liver fibrosis markers, including the Aspartate Aminotransferase Platelet Ratio Index (APRI) and FIB-4, between patients with hypertensive disorders of pregnancy (HDP) and healthy controls and to investigate the association between these markers and adverse maternal and perinatal outcomes. Methods: In this retrospective case-control study, 205 patients with HDP and 192 normotensive controls were included for evaluation. Demographic data, laboratory findings, and maternal and perinatal outcomes were compared. FIB-4 and APRI scores were calculated using second-trimester AST, ALT, and platelet levels. ROC curve analysis was used to assess the predictive accuracy of these indices for HELLP syndrome and other complications. Linear regression analysis was applied to evaluate the parameters associated with the FIB-4 score. Results: FIB-4 and APRI scores were significantly higher in patients with HDP compared to controls (p<0.05). Among patients with severe preeclampsia and HELLP syndrome, fibrosis scores were markedly elevated. FIB-4 and APRI showed excellent diagnostic performance for HELLP syndrome (AUC: 0.976 and 0.992, respectively), with optimal cutoffs of 1.52 and 0.7. However, their predictive role for general adverse maternal and perinatal outcomes was limited. In multivariate regression, systolic blood pressure, maternal age, and adverse maternal outcomes were independent predictors of increased FIB-4 scores (p<0.05). Conclusions: FIB-4 and APRI may be considered simple, noninvasive indices that could contribute to early risk stratification for HELLP syndrome among patients with HDP. Although their predictive capacity remains to be validated in larger prospective studies, they may offer preliminary insights into hepatic dysfunction during pregnancy.
- 20 June 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (12) , 2055-2062
Maternal liver fibrosis indices as predictors of adverse perinatal outcomes in patients with gestational diabetes mellitus
Objective This study aimed to evaluate the FIB-4 and APRI scores in patients with gestational diabetes mellitus (GDM) and investigate their associations with neonatal outcomes. Additionally, the predictive value of these non-invasive fibrosis indices for GDM and adverse perinatal outcomes was assessed. Materials and methods In this retrospective case-control study, 200 pregnant women diagnosed with GDM and 200 healthy controls were analyzed. Data on maternal demographics, laboratory parameters (ALT, AST, platelet count), FIB-4 and APRI scores, perinatal and neonatal outcomes including fetal growth restriction (FGR), oligohydramnios, polyhydramnios, birth weight, gestational age at birth, neonatal cord blood pH, neonatal hypoglycemia, Apgar 1 min. and 5 min. scores, and neonatal intensive care unit (NICU) admission were collected. Logistic regression analyses were performed to identify independent predictors of adverse perinatal outcomes among GDM patients. ROC analysis was used to determine the diagnostic performance of both indices. Results FIB-4 and APRI scores were significantly higher in GDM patients compared to controls (p < 0.05). Among GDM patients, those with FGR, NICU admission, or neonatal death had significantly elevated FIB-4 scores. Stratification by FIB-4 risk categories revealed that patients with high FIB-4 scores had increased rates of FGR, fetal hypoglycemia, adverse perinatal outcomes, and NICU admission (p < 0.01). ROC analysis for predicting GDM yielded AUC values of 0.577 for FIB-4 and 0.571 for APRI. For predicting adverse perinatal outcomes, the FIB-4 AUC was 0.590, while APRI showed limited predictive ability (AUC = 0.511). Conclusion FIB-4 can serve as a valuable non-invasive marker for liver dysfunction in GDM and is significantly associated with adverse perinatal outcomes. Despite limited predictive power, these scores may serve as early indicators of hepatic involvement in GDM.
- 20 June 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (12) , 2055-2062
Maternal liver fibrosis indices as predictors of adverse perinatal outcomes in patients with gestational diabetes mellitus
Objective This study aimed to evaluate the FIB-4 and APRI scores in patients with gestational diabetes mellitus (GDM) and investigate their associations with neonatal outcomes. Additionally, the predictive value of these non-invasive fibrosis indices for GDM and adverse perinatal outcomes was assessed. Materials and methods In this retrospective case-control study, 200 pregnant women diagnosed with GDM and 200 healthy controls were analyzed. Data on maternal demographics, laboratory parameters (ALT, AST, platelet count), FIB-4 and APRI scores, perinatal and neonatal outcomes including fetal growth restriction (FGR), oligohydramnios, polyhydramnios, birth weight, gestational age at birth, neonatal cord blood pH, neonatal hypoglycemia, Apgar 1 min. and 5 min. scores, and neonatal intensive care unit (NICU) admission were collected. Logistic regression analyses were performed to identify independent predictors of adverse perinatal outcomes among GDM patients. ROC analysis was used to determine the diagnostic performance of both indices. Results FIB-4 and APRI scores were significantly higher in GDM patients compared to controls (p < 0.05). Among GDM patients, those with FGR, NICU admission, or neonatal death had significantly elevated FIB-4 scores. Stratification by FIB-4 risk categories revealed that patients with high FIB-4 scores had increased rates of FGR, fetal hypoglycemia, adverse perinatal outcomes, and NICU admission (p < 0.01). ROC analysis for predicting GDM yielded AUC values of 0.577 for FIB-4 and 0.571 for APRI. For predicting adverse perinatal outcomes, the FIB-4 AUC was 0.590, while APRI showed limited predictive ability (AUC = 0.511). Conclusion FIB-4 can serve as a valuable non-invasive marker for liver dysfunction in GDM and is significantly associated with adverse perinatal outcomes. Despite limited predictive power, these scores may serve as early indicators of hepatic involvement in GDM.
- Open Access
- 1 June 2025
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 38 (1) , 2512440
Letter to editor: spontaneous conversion of fetal heart block to sinus rhythm post-externalized pacemaker placement in an undiagnosed mother with lupus antibodies
- 1 June 2025
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 38 (1) , 2512440
Open AccessLetter to editor: spontaneous conversion of fetal heart block to sinus rhythm post-externalized pacemaker placement in an undiagnosed mother with lupus antibodies